Sheila Mikhail - 16 Jun 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, Attorney-in-Fact
Issuer symbol
VERV
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
3
Filing time
16 Jun 2021, 19:38:21 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERV Stock Option (right to buy) 16 Jun 2021 Common Stock 43,198 $8.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 1, 2021 for 43,198 shares. The shares underlying the option vest quarterly over 4 years in 16 equal quarterly installments, with the first installment commencing on April 1, 2021.

Remarks:

Exhibit Index: 24.1 Power of Attorney